Martin Tami Tillotson has filed 23 insider transactions across 1 company since January 2023.
Most recent transaction: a tax payment of 485 shares of SUPERNUS PHARMACEUTICALS, INC. ($SUPN) on February 23, 2024.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | F | Common Stock | 485 | $29.06 | 86,933.0000 | 55,506,828 | 0.55% | 0.00% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | D | Restricted Stock Unit | 1250 | $0.00 | 3,750.0000 | 55,506,828 | 25.00% | 0.00% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | A | Common Stock | 1250 | $0.00 | 87,418.0000 | 55,506,828 | 1.45% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | A | Common Stock | 750 | $0.00 | 86,414.0000 | 55,506,828 | 0.88% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | F | Common Stock | 246 | $27.94 | 86,168.0000 | 55,506,828 | 0.28% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | D | Restricted Stock Units | 750 | $0.00 | 1,500.0000 | 55,506,828 | 33.33% | 0.00% |
| Jan. 10, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | M | Common Stock | 8000 | $9.24 | 93,664.0000 | 55,506,828 | 9.34% | 0.01% |
| Jan. 10, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | S | Common Stock | 8000 | $27.91 | 85,664.0000 | 55,506,828 | 8.54% | 0.01% |
| Jan. 10, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | M | Employee Stock Option (Right to Buy) | 8000 | $0.00 | 0.0000 | 55,506,828 | 100.00% | 0.01% |
| Aug. 30, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | M | Employee Stock Option (Right to Buy) | 8100 | $0.00 | 13,900.0000 | 61,679,800 | 36.82% | 0.01% |
| Aug. 30, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | M | Common Stock | 8100 | $23.99 | 93,349.0000 | 61,679,800 | 9.50% | 0.01% |
| Aug. 30, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | S | Common Stock | 8100 | $32.00 | 85,249.0000 | 61,679,800 | 8.68% | 0.01% |
| Aug. 25, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | S | Common Stock | 5135 | $31.59 | 85,249.0000 | 61,679,800 | 5.68% | 0.01% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | A | Common Stock | 750 | $0.00 | 90,323.0000 | 61,679,800 | 0.84% | 0.00% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | D | Restricted Stock Units | 750 | $0.00 | 2,250.0000 | 61,679,800 | 25.00% | 0.00% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | F | Common Stock | 289 | $38.57 | 90,034.0000 | 61,679,800 | 0.32% | 0.00% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | A | Employee Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 61,679,800 | 9999.99% | 0.03% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | A | Restricted Stock Units | 5000 | $0.00 | 5,000.0000 | 61,679,800 | 9999.99% | 0.01% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | D | Restricted Stock Units | 750 | $0.00 | 2,250.0000 | 61,679,800 | 25.00% | 0.00% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | A | Common Stock | 750 | $0.00 | 90,323.0000 | 61,679,800 | 0.84% | 0.00% |
| Feb. 16, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | M | Performance Share Unit | 1500 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.00% |
| Feb. 16, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | M | Common Stock | 1500 | $0.00 | 88,720.0000 | 61,679,800 | 1.72% | 0.00% |
| Jan. 12, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | A | Performance Share Unit | 1500 | $0.00 | 1,500.0000 | 61,679,800 | 9999.99% | 0.00% |